The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapy
暂无分享，去创建一个
A. Rossi | M. Ladetto | D. Caracciolo | G. Gritti | A. Rambaldi | R. Passera | A. Gianni | A. Barbui | C. Patti | A. Gueli | C. Tarella | E. Oldani | C. Boschini | A. Crescenzo | F. Delaini | L. Devizzi